Detalles de la búsqueda
1.
Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
J Infect Dis
; 229(4): 1068-1076, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37673423
2.
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations.
BMJ Glob Health
; 9(6)2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38857947
3.
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial.
Lancet Infect Dis
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552653
4.
Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Vaccine
; 41(51): 7587-7597, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37993355
Resultados
1 -
4
de 4
1
Próxima >
>>